Compare EOT & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EOT | TCMD |
|---|---|---|
| Founded | 2009 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.6M | 300.1M |
| IPO Year | N/A | 2016 |
| Metric | EOT | TCMD |
|---|---|---|
| Price | $17.37 | $30.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $27.00 |
| AVG Volume (30 Days) | 38.7K | ★ 320.0K |
| Earning Date | 01-01-0001 | 02-17-2026 |
| Dividend Yield | ★ 4.51% | N/A |
| EPS Growth | N/A | ★ 18.66 |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $311,513,000.00 |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | N/A | $8.83 |
| P/E Ratio | ★ N/A | $39.77 |
| Revenue Growth | N/A | ★ 9.28 |
| 52 Week Low | $14.63 | $8.61 |
| 52 Week High | $18.30 | $31.13 |
| Indicator | EOT | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 63.97 | 63.27 |
| Support Level | $17.05 | $29.11 |
| Resistance Level | $17.49 | $30.87 |
| Average True Range (ATR) | 0.25 | 1.05 |
| MACD | 0.04 | -0.15 |
| Stochastic Oscillator | 83.52 | 85.24 |
Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. The company invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.